Last updated on September 2018

A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of AGB101on Slowing Progression of Mild Cognitive Impairment Due to Alzheimer's Disease


Other Details:

AGB101 MCD



Find a site near you

Start Over